GNI Group Ltd.

Insider Reports History

Entity
Company
Location
Nihonbashi Honcho Ys Bldg 3 F, 2 2 2 Nihonbashi Honcho, Chuo Ku, Tokyo, Japan
Signature
/s/ Branden Berns, as attorney-in-fact for GNI Group Ltd.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GNI Group Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GYRE THERAPEUTICS, INC. 10%+ Owner Common Stock 64M $30.1M $0.47 Oct 30, 2023 See Remarks
GYRE THERAPEUTICS, INC. 10%+ Owner Series X Convertible Preferred Stock Warrant (Right to Buy) 8.11M $1.01M $0.13 Oct 27, 2023 Indirect
GYRE THERAPEUTICS, INC. 10%+ Owner Series X Convertible Preferred Stock 13.2K Oct 27, 2023 Indirect
CATALYST BIOSCIENCES, INC. 10%+ Owner Series Y Preferred Stock 0 Aug 31, 2023 Direct

Insider Reports Filed by GNI Group Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GYRE GYRE THERAPEUTICS, INC. Oct 30, 2023 1 $0 4 Nov 22, 2023 10%+ Owner
CBIO GYRE THERAPEUTICS, INC. Oct 27, 2023 2 $5M 4 Oct 31, 2023 10%+ Owner
CBIO CATALYST BIOSCIENCES, INC. Oct 27, 2023 0 $0 3 Oct 27, 2023 10%+ Owner
CBIO CATALYST BIOSCIENCES, INC. Aug 31, 2023 2 $0 4 Sep 1, 2023 10%+ Owner
CBIO CATALYST BIOSCIENCES, INC. Dec 26, 2022 0 $0 3 Jan 5, 2023 10%+ Owner